What did @lifeofstogie actually say?
The creator laid out a self-managed protocol for controlling estrogen while using testosterone or anabolic steroids. The core argument: estrogen mismanagement is the hardest part of TRT, symptoms alone can tell you whether it is too high or too low, and you can self-titrate an aromatase inhibitor called aromasin (exemestane) based on those symptoms. He flagged "itchy nipples" and a tingling sensation when hot as personal high-estrogen tells, and "dry skin and low libido" as low-estrogen signs. His fix for high estrogen was to "take aromasin," and for low estrogen, to "take less aromasin." He also recommended daily injections to smooth hormone fluctuations and a DIM supplement as adjuncts. The video is aimed at people already using gear, not necessarily people on physician-supervised TRT.
Does the science back this up?
Some of this is grounded in real endocrinology. The rest is gym-bro pattern-matching dressed up as clinical guidance, and the self-dosing advice is where things get genuinely risky.
Estrogen's role in male physiology is well-documented. Men need estradiol for bone mineral density, cardiovascular function, libido, and cognitive health. A 2016 review by Finkelstein et al. in the New England Journal of Medicine confirmed that estrogen, not just testosterone, drives libido and fat distribution in men. So the creator is right that estrogen is important and that crashing it is a real problem.
Where the science gets more complicated is symptom-based diagnosis. A 2021 study by Ramasamy et al. in the Journal of Urology found that symptoms of low and high estradiol overlap substantially in men on TRT, making clinical symptoms unreliable as a sole diagnostic tool. "You know your estrogen is fucked" based on texting your ex is not a validated screening protocol.
What did they get wrong (or right)?
Credit where it is due: the creator correctly identifies that both high and low estrogen cause low libido, which confuses a lot of men on TRT. That is an accurate and genuinely useful flag. Daily pinning to reduce peak-to-trough hormone swings is also supported by pharmacokinetic data on testosterone cypionate and enanthate (Bhasin et al., 2001, Journal of Clinical Endocrinology and Metabolism).
What is wrong, and not slightly wrong: recommending that someone self-titrate an aromatase inhibitor without bloodwork is dangerous advice. Exemestane is a potent, irreversible aromatase inhibitor. Estrogen crash in men is associated with bone loss, endothelial dysfunction, and severe mood disruption (Finkelstein et al., 2016, NEJM). The symptom overlap the creator himself acknowledges, noting low libido happens with both high and low estrogen, is exactly why bloodwork exists. Suggesting someone bounce between doses until they find "the correct aromasin dose" is titration without a safety net.
DIM (diindolylmethane) as an estrogen modulator has limited human trial data. Most evidence is in vitro or animal-based. Presenting it as a reliable estrogen management tool overstates the current evidence.
What should you actually know?
If you are on TRT and worried about estrogen, the only reliable way to assess it is serum estradiol testing, specifically a sensitive assay (LC-MS/MS), not a standard immunoassay, which can overestimate estradiol in men (Taieb et al., 2003, Clinical Chemistry). Symptoms are a starting point for a conversation with a clinician, not a dosing trigger.
Aromatase inhibitors are not universally required on TRT. Many men on physiologic testosterone doses do not need them at all. The reflexive use of AIs to suppress estrogen has been associated with worse cardiovascular risk profiles in some studies (Lopes et al., 2020, JAMA Oncology, primarily in cancer populations but with relevant mechanistic data).
- Get bloodwork before adjusting any hormone-related medication.
- Sensitive estradiol assays (LC-MS/MS) are the standard for men, not the standard immunoassay panel.
- Symptom overlap between high and low estrogen is real and documented. Do not self-diagnose.
- Exemestane is not an over-the-counter supplement. Dosing it without clinical supervision carries real risk.
- DIM has limited human evidence as an estrogen management tool. It is not a clinical substitute for an AI or for monitoring.